SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-117768
Filing Date
2010-12-30
Accepted
2010-12-30 16:10:13
Documents
1
Period of Report
2010-12-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f57721e8vk.htm 8-K 14279
  Complete submission text file 0000950123-10-117768.txt   16573
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 101281343
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 101281342
SIC: 8060 Services-Hospitals